Table 5 Baseline characteristics stratified by sex
Variable | Overall n = 230 | Men n = 168 | Women n = 62 | p-value |
|---|---|---|---|---|
Age | 62 ± 10 | 62 ± 10 | 61 ± 9 | 0.37 |
BMI, kg/m2 | 30.6 ± 4.8 | 31.4 ± 5.8 | 30.3 ± 4.3 | 0.09 |
Hypertension, n (%) | 160 (70) | 43 (66) | 117 (71) | 0.97 |
Hypercholesterolemia, n (%) | 179 (78) | 128 (76) | 51 (82) | 0.34 |
Current smoker, n (%) | 53 (23) | 41 (24) | 12 (19) | 0.42 |
Pack years | 15.9 ± 19.2 | 17.5 ± 20.1 | 11.6 ± 15.9 | 0.04 |
Laboratory findings | ||||
 LDL cholesterol, mmol/L | 1.99 ± 0.81 | 1.94 ± 0.82 | 2.12 ± 0.78 | 0.13 |
 HDL cholesterol, mmol/L | 1.3 ± 0.7 | 1.2 ± 0.7 | 1.3 ± 0.4 | 0.37 |
 HbA1c, mmol/mol | 60.0 ± 14.4 | 61.5 ± 14.4 | 55.9 ± 12.7 |   0.01 |
 CACS, median [IQR] | 72.5 [1;460] | 137.0 [13;699] | 4 0.0 [0;121] |  < 0.001 |
 Duration of diabetes, years | 10.9 ± 8.0 | 11.1 ± 8.2 | 10.4 ± 7.4 | 0.55 |
 Lipid-lowering duration, years | 5.3 ± 5.7 | 5.3 ± 5.8 | 5.4 ± 5.4 | 0.86 |
 Diabetic complications, n (%) | 123 (54) | 55 (64) | 68 (47) | 0.01 |
Medication | ||||
 Lipid-lowering, n (%) | 178 (77) | 127 (76) | 51 (82) | 0.28 |
 Insulin, n (%) | 90 (39) | 69 (41) | 21 (52) | 0.32 |